Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEAVUE: Ustekinumab vs Adalimumab in Crohn's Disease
NCT03464136Phase 3Completed
- Sponsor
- Janssen Scientific Affairs
- Start
- Mar 2018
- Primary completion
- Dec 2020
- Modality
- Monoclonal Antibodies
- Countries
- 18
01
Overview
A Phase 3 trial of ustekinumab in Crohn's disease, sponsored by Janssen Scientific Affairs. Started Mar 2018; status: completed.
02
Drugs
ustekinumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT03464136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03464136.